BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Prognosis
1273 results:

  • 1. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
    BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
    Zeng F; Guo P; Xia M; He M
    J Cancer Res Clin Oncol; 2024 May; 150(5):236. PubMed ID: 38710946
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluating the clinical efficacy and safety of concurrent chemoradiotherapy with cisplatin and nab-paclitaxel in postoperative early-stage cervical cancer.
    Zhao N; Li Y; Chen X; Ma J; Luo W; Li Y
    J Cancer Res Clin Oncol; 2024 May; 150(5):233. PubMed ID: 38709400
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification and Quantification of Radiotherapy-related Protein Expression in cancer Tissues Using the Qupath Software and Prediction of Treatment Response.
    Hasegawa T; Someya M; Tsuchiya T; Kitagawa M; Fukushima Y; Gocho T; Mafune S; Okuda R; Kaguchi J; Ohguro A; Kamiyama R; Ashina A; Toshima Y; Hirohashi Y; Torigoe T; Sakata KI
    In Vivo; 2024; 38(3):1470-1476. PubMed ID: 38688633
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
    Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
    BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [
    Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
    BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]    [Full Text] [Related]  

  • 8. Sarcoma of the uterine cervix: experience of a single center.
    Yuan H; Li L; Li N; Yao H
    World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
    Zhang Y; Li L; Han Q; Wen L
    J Obstet Gynaecol; 2024 Dec; 44(1):2333784. PubMed ID: 38602239
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study.
    Zeng S; Yang P; Xiao S; Liu L
    Sci Rep; 2024 Apr; 14(1):7681. PubMed ID: 38561337
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Intraoperative frozen section pathology of vaginal margin in radical hysterectomy on the prognosis and quality of life for patients with IB2-IIA2 cervical cancer: study protocol for a multicenter randomized controlled trial.
    Liu Y; Xin W; Wang P; Ji M; Guo X; Ouyang Y; Zhao D; Hua K
    J Gynecol Oncol; 2024 May; 35(3):e81. PubMed ID: 38522951
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
    Olaleye OO; Kim DH; Spriggs KA
    BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Adenoid cystic carcinoma of the parotid and submandibular glands in children and young adults: A population-based study.
    Phillips AL; Li C; Liang J; Sheyn A; Rastatter JC; Chelius DC; Orbach D; Richard C
    Pediatr Blood Cancer; 2024 May; 71(5):e30928. PubMed ID: 38418934
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Retrospective Analysis of All Types of Adjuvant Radiotherapy in Endometrial cancer: Single-Center Experiences in a Middle-Income Country.
    Chitapanarux N; Tharavichitkul E; Kittidachanan K; Muangwong P; Chakrabandhu S; Klunklin P; Onchan W; Jia-Mahasap B; Torapichattrakul P; Chitapanarux I
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):485-494. PubMed ID: 38415534
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
    Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
    Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Serum squamous cell carcinoma antigen level and magnetic resonance imaging for the prognosis of locally advanced cervical cancer.
    Gu LN; Yu JW; Jiang L; Liu TB; Xu Y
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):668-678. PubMed ID: 38305609
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinicopathologic Characteristics of Thyroid Microcarcinoma: Findings from a Hospital-Based Study in Vietnam.
    Nguyen BQ; Vu HT; Nguyen LMT; Nguyen QH; Paragomi P; Luu HN
    Discov Med; 2024 Jan; 36(180):209-216. PubMed ID: 38273761
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Zhao D; Sun S; Yang Z; Wang P; Qiu H
    Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/AKT axis and VEGF-C secretion.
    Mei X; Xiong J; Liu J; Huang A; Zhu D; Huang Y; Wang H
    Cancer Lett; 2024 Mar; 584():216609. PubMed ID: 38211648
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
    Friedman CF; D'Souza A; Bello Roufai D; Tinker AV; de Miguel M; Gambardella V; Goldman J; Loi S; Melisko ME; Oaknin A; Spanggaard I; Shapiro GI; ElNaggar AC; Panni S; Ravichandran V; Frazier AL; DiPrimeo D; Eli LD; Solit DB
    Gynecol Oncol; 2024 Feb; 181():162-169. PubMed ID: 38211393
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 64.